Skip to main content

CHD7 Antibody - BSA Free

Novus Biologicals, part of Bio-Techne | Catalog # NBP1-77393

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP1-77393SS
NBP1-77393

Key Product Details

Species Reactivity

Validated:

Human, Mouse

Cited:

Human

Applications

Validated:

Immunocytochemistry/ Immunofluorescence, Immunohistochemistry, Immunohistochemistry-Paraffin, Western Blot

Cited:

Immunocytochemistry/ Immunofluorescence, Immunohistochemistry-Paraffin, Western Blot

Label

Unconjugated

Antibody Source

Polyclonal Rabbit IgG

Format

BSA Free

Concentration

1 mg/ml

Product Specifications

Immunogen

A genomic peptide made to an N-terminal region of the human Chd7 protein (within residues 25-200). [Swiss-Prot Q9P2D1]

Reactivity Notes

Human and mouse. Immunogen has 85% identity to chicken Chd7.

Localization

Nucleus

Clonality

Polyclonal

Host

Rabbit

Isotype

IgG

Scientific Data Images for CHD7 Antibody - BSA Free

Immunocytochemistry/ Immunofluorescence: CHD7 Antibody - BSA Free [NBP1-77393]

Immunocytochemistry/ Immunofluorescence: CHD7 Antibody - BSA Free [NBP1-77393]

Immunocytochemistry/Immunofluorescence: Chd7 Antibody [NBP1-77393] - Antibody was tested in NIH/3T3 cells with FITC (green). Nuclei and actin were counterstained with Dapi (blue) and Phalloidin (red).
Immunohistochemistry: CHD7 Antibody - BSA Free [NBP1-77393]

Immunohistochemistry: CHD7 Antibody - BSA Free [NBP1-77393]

Immunohistochemistry: Chd7 Antibody [NBP1-77393] - IHC analysis of CHD7 in mouse intestine using DAB with hematoxylin counterstain.

Applications for CHD7 Antibody - BSA Free

Application
Recommended Usage

Immunocytochemistry/ Immunofluorescence

1:100

Immunohistochemistry

1:250

Immunohistochemistry-Paraffin

1:250

Western Blot

1:2500
Application Notes
This CHD7 antibody is useful for IHC-P, ICC/IF and Western blot where a band is seen ~330 kDa. Prior to immunostaining paraffin tissues, antigen retrieval with sodium citrate buffer (pH 6.0) is recommended.

Reviewed Applications

Read 1 review rated 5 using NBP1-77393 in the following applications:

Formulation, Preparation, and Storage

Purification

Immunogen affinity purified

Formulation

PBS and 30% Glycerol

Format

BSA Free

Preservative

0.05% Sodium Azide

Concentration

1 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: CHD7

CHARGE syndrome (coloboma, heart defects, atresia of the choanae, retarded growth and development, genital hypoplasia, ear anomalies and deafness) is a congenital malformation syndrome caused by mutations in the CHD7 (chromodomain helicase DNA-binding protein) gene in approximately 2/3 of cases. In Kallmann syndrome, a similar proportion of affected individuals also have mutated CHD7. These mutations probably affect neurogenerative anomalies and maturation events through SOX2 interaction. Expression patterns of CHD7 in combination with SOX2 evaluation can provide some insight into molecular causes of CHARGE and Kallmann syndromes.

Long Name

Chromodomain Helicase DNA Binding Protein 7

Alternate Names

ATP-dependent helicase CHD7, CHD-7, chromodomain helicase DNA binding protein 7, chromodomain helicase DNA binding protein 7 isoform CRA_e, chromodomain-helicase-DNA-binding protein 7, EC 3.6.1, EC 3.6.4.12, FLJ20357, FLJ20361, IS3, KIAA1416KAL5

Entrez Gene IDs

55636 (Human); 320790 (Mouse)

Gene Symbol

CHD7

Additional CHD7 Products

Product Documents for CHD7 Antibody - BSA Free

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for CHD7 Antibody - BSA Free

Manufactured by Genomic Antibody Technology™. GAT FAQs

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...
Loading...